CompletedNot Applicable

Intervention to Improve HIV Self-care Among People Who Inject Drugs

United States42 participantsStarted 2021-09-01

Plain-language summary

This study will implement a pilot randomized controlled trial (RCT, N=50) to refine and assess the feasibility and acceptability of an emotion regulation and communication skills intervention designed to improve engagement in HIV-care among HIV+ people who report opioid and/or stimulant use and are sub-optimally engaged in HIV care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * HIV positive * HIV virally unsuppressed (\>20 copies/mL) in past year or no past-year HIV viral load result * Opioid and/or stimulant use behavior endorsed in past 6 months * Able to provide informed consent * 18 years or older * English speaking Exclusion Criteria: * HIV negative * Denying drug use in past 6 months

What they're measuring

Feasibility of iSTRIVE intervention

Timeframe: change from baseline to 12 weeks after intervention completion

Feasibility of iDOT intervention

Timeframe: change from baseline to 12 weeks after intervention completion

Acceptability of intervention

Timeframe: 12 weeks after intervention completion

Trial details

NCT IDNCT05819411

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-31

View on ClinicalTrials.gov More Hiv trials